A Framework for Patient-Centered Pathways of Care for Radiopharmaceutical Therapy: An ASTRO Consensus Document

Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial

Matthew R. Smith, Chris Parker, Fred Saad et al. · The Lancet Oncology · 2019 · 397 citations · Full text

Medicine, Oncology, Urology +16

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

Ulrike Garske‐Román, Mattias Sandström, Katarzyna Fröss Baron et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 249 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response—Implications for Radionuclide Therapy

Barry W. Wessels, Mark Konijnenberg, Roger Dale et al. · Journal of Nuclear Medicine · 2008 · 190 citations · Full text

Medicine, Nuclear Medicine, Radiation Oncology +17

Patient-Centered Cancer Treatment Planning: Improving the Quality of Oncology Care. Summary of an Institute of Medicine Workshop

Erin P. Balogh, Patricia A. Ganz, Sharon B. Murphy et al. · The Oncologist · 2011 · 150 citations · Full text

Medicine, Oncology, Health Communication +16

High impact of macroaggregated albumin‐based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with ⁹⁰Y‐loaded glass microsphere radioembolization

Étienne Garin, Yan Rolland, Marc Pracht et al. · Liver International · 2016 · 96 citations · Full text

Medicine, Oncology, Radiology +9